Activated protein C enhances human keratinocyte barrier integrity via sequential activation of epidermal growth factor receptor and Tie2

J Biol Chem. 2011 Feb 25;286(8):6742-50. doi: 10.1074/jbc.M110.181388. Epub 2010 Dec 20.

Abstract

Keratinocytes play a critical role in maintaining epidermal barrier function. Activated protein C (APC), a natural anticoagulant with anti-inflammatory and endothelial barrier protective properties, significantly increased the barrier impedance of keratinocyte monolayers, measured by electric cell substrate impedance sensing and FITC-dextran flux. In response to APC, Tie2, a tyrosine kinase receptor, was rapidly activated within 30 min, and relocated to cell-cell contacts. APC also increased junction proteins zona occludens, claudin-1 and VE-cadherin. Inhibition of Tie2 by its peptide inhibitor or small interfering RNA abolished the barrier protective effect of APC. Interestingly, APC did not activate Tie2 through its major ligand, angiopoietin-1, but instead acted by binding to endothelial protein C receptor, cleaving protease-activated receptor-1 and transactivating EGF receptor. Furthermore, when activation of Akt, but not ERK, was inhibited, the barrier protective effect of APC on keratinocytes was abolished. Thus, APC activates Tie2, via a mechanism requiring, in sequential order, the receptors, endothelial protein C receptor, protease-activated receptor-1, and EGF receptor, which selectively enhances the PI3K/Akt signaling to enhance junctional complexes and reduce keratinocyte permeability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Communication / drug effects
  • Cell Communication / physiology*
  • Enzyme Activation / drug effects
  • Enzyme Activation / physiology
  • ErbB Receptors / metabolism*
  • Humans
  • Infant, Newborn
  • Intercellular Junctions / metabolism
  • Keratinocytes / cytology
  • Keratinocytes / metabolism*
  • Male
  • Peptides / pharmacology
  • Permeability
  • Phosphatidylinositol 3-Kinases / genetics
  • Phosphatidylinositol 3-Kinases / metabolism
  • Protein C / metabolism*
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-akt
  • RNA, Small Interfering
  • Receptor, PAR-1 / genetics
  • Receptor, PAR-1 / metabolism
  • Receptor, TIE-2 / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology

Substances

  • Peptides
  • Protein C
  • Protein Kinase Inhibitors
  • RNA, Small Interfering
  • Receptor, PAR-1
  • Phosphatidylinositol 3-Kinases
  • EGFR protein, human
  • ErbB Receptors
  • Receptor, TIE-2
  • Proto-Oncogene Proteins c-akt